Academic Partners: This initiative builds on an existing research consortium with Boston University and the University of Houston. Discussions are also in progress with universities including Brandeis University, Notre Dame University, Oxford University (U.K.), Universidad Complutense (Madrid, Spain), Université Paris-Saclay, Leiden University, Beijing Normal University, among others. 

Global Organizations: We are partnered with the Pharmaceutical Security Institute, Thomson Reuters Special Services, Western Union and the Global Initiative against Transnational Organized Crime and U.S. federal agencies such as DHS/HSI and FDA. Strategic planning conversations are currently underway with the following U.S. and international entities: the Transported Assets Protection Association (TAPA), the Financial Crimes Enforcement Network (a bureau of the U.S. Department of Treasury); the World Health Organization, the Organization for Economic Co-operation and Development (OECD), the World Bank, the African Development Bank, the Asian Development Bank, the Inter-American Development Bank, the IMF, Europol, EU investigative agencies, the Council of Europe, and the Institute of Research against Counterfeit Medicines.

Industrial Partners: We are in conversation with several pharmaceutical companies including Pfizer, Inc., Moderna, Inc. and Sanofi.